Midkine (114-122)
|
|
|
mTERT (572-580)
|
|
|
Midkine (9-23)
|
|
|
Miraculin (1-20)
|
ASP-SER-ALA-PRO-ASN-PRO-VAL-LEU-ASP-ILE-ASP-GLY-GLU-LYS-LEU-ARG-THR-GLY-THR-ASN
|
198694-37-0
|
Microsomal glutathione S-transferase 1 isoform a (121-132)
|
|
|
Microtubule-associated protein 1A (806-814)
|
|
|
MGAT5 (intro)
|
|
|
Moth Cytochrome C (MCC) 88-103
|
|
108273-68-3
|
Midkine (13-21)
|
|
|
MUC5AC motif peptide
|
MUC5AC motif peptide
|
244049-41-0
|
Midasin (1471-1481)
|
|
|
MLH3 protein, partial (135-151)
|
|
|
mTRP-2 (180-188)
|
MTRP-2 (180-188)
|
219312-69-3
|
Melanoma-associated antigen C2 (307-315)
|
|
|
Melanoma-associated antigen C2 (43-57)
|
|
|
Melanoma antigen preferentially expressed in tumors (301-309)
|
|
|
Metalloreductase STEAP1 (292-300)
|
|
|
Melanoma-associated antigen C2 (336-344)
|
|
|
Melanoma-associated antigen C1 (137-149)
|
|
|
Metalloreductase STEAP1 (102-116)
|
|
|
Melanoma-associated antigen C1 (1083-1091)
|
|
|
Melanoma-associated antigen C1 (779-787)
|
|
|
Melanoma-associated antigen C1 (959-968)
|
|
|
Melanoma antigen preferentially expressed in tumors (425-433)
|
|
|
Melanoma-associated antigen C2 (42-50)
|
|
|
Melanoma antigen preferentially expressed in tumors (142-151)
|
|
|
Melanoma-associated antigen C2 (191-200)
|
|
|
Melanoma-associated antigen C1 (450-458)
|
|
|
melanoma-overexpressed antigen 1 (24-37)
|
|
|
Melanoma antigen preferentially expressed in tumors (300-309)
|
|
|
melanoma-overexpressed antigen 1 (36-44)
|
|
|
melanoma-overexpressed antigen 1 (31-44)
|
|
|
Melanoma antigen preferentially expressed in tumors (100-108)
|
|
|
melanoma-overexpressed antigen 1 (11-23)
|
|
|
MART 1 peptide (1-10)
|
|
|
MART-1 (51-73)
|
|
|
Matrix protein 1 (27-35)
|
|
|
MART-1 (97-116)
|
|
|
Melanocyte protein Pmel 17 precursor (40-57)
|
|
|
Melanoma antigen gp100 (280-288)
|
|
|
Melanocyte protein Pmel 17 precursor (46-57)
|
|
|
Melanocyte protein Pmel 17 precursor (45-57)
|
|
|
MART-1 (32-40)
|
|
|
MART-1 (91-110)
|
|
|
Melanocyte protein Pmel 17 precursor (44-57)
|
|
|
Matrilysin (96-107)
|
|
|
MART-1 (51-61)
|
|
|
Matrix protein 1 (229-237)
|
|
|
N-terminally acetylated Endomorphin-1
|
N-terminally acetylated Endomorphin-1
|
|
NAD-dependent protein deacetylase sirtuin-2 (192-200)
|
|
|
NADP-dependent malic enzyme (224-232)
|
|
|
NUAK family SNF1-like kinase 2 (446-455)
|
|
|
Mucin-1 (950-958)
|
|
|
Murine Survivin (20-28)
|
|
|
Mucin-1 precursor (12-20)
|
|
|
Mucin-5AC (716-724)
|
|
|
MUM3 (322-330)
|
|
|
N-Acetyl-Phe-Octreotide
|
奧曲肽雜質(zhì)1
|
83795-61-3
|
Murine Survivin (97-104)
|
|
|
Mucin-1 (repeated region)
|
|
|
PA (224-233), Influenza
|
PA (224–233), Influenza
|
271573-27-4
|
PAP-3 (135-143)
|
|
|
Perilipin-2 (129-137)
|
|
|
OVA (241-270)
|
OVA (241-270)
|
2648610-97-1
|
Peroxiredoxin-5, mitochondrial (163-172)
|
|
|
NY-ESO-1 (161-180)
|
|
|
p53 (139-147)
|
|
|
papillomavirus binding factor (499-510)
|
|
|
p14ARF-ORF3 (125-133)
|
|
|
p53 (149-157)
|
|
|
NY-CO-13 (187-197)
|
|
|
NY-CO-13 (139-147)
|
|
|
Nuclear pore complex protein Nup98 (315-360)
|
|
|
Nucleoprotein (265-273)
|
|
|
PACAP-Related Peptide (PRP), human
|
ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA
|
|
p53 (103-111)
|
|
|
p53 17-26
|
ETFSDLWKLL
|
488118-64-5
|
NY-ESO-1 (155-163)
|
|
|
Nuclear transcription factor Y subunit gamma (275-282)
|
|
|
NY-ESO-1 peptide (1-9)
|
|
|
Paired box protein Pax-5 (311-319)
|
|
|
Nuclear transcription factor Y subunit gamma (28-37)
|
|
|
Nucleoprotein 396-404
|
NUCLEOPROTEIN 396-404;NP 396
|
158475-79-7
|
Nucleoprotein 118-126
|
124454-83-7
|
124454-83-7
|
NY-ESO-1 (157-165)
|
|
|
Prohormone Convertase 2
|
|
|
Poly(A) polymerase gamma (724-734)
|
|
|
Procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 (388-401)
|
|
|
PMEL (25-33)
|
|
|
Phe-CO-Arg-Val-DPhe
|
Phe-CO-Arg-Val-D-Phe-H
|
83830-01-7
|
Polypyrimidine tract-binding protein 1 isoform b (359-373)
|
|
|
Pinealon
|
Pinealon
|
|
POTE ankyrin domain family member F (795-804)
|
|
|
Polycystic kidney disease 1 protein (4192-4202)
|
|
|
Programmed cell death 1 ligand 1 (15-23)
|
|
|
(Prolyl-hydroxylprolyl-glycine)10
|
(PROLYL-HYDROXYLPROLYL-GLYCINE)10
|
40350-90-1
|
Prostate Specific Antigen-1 (153-161)
|
|
|
Prostate-specific antigen (178-187)
|
|
|
Prostate Specific Antigen (146-154)
|
|
|
Prostate-specific antigen (165-174)
|
|
|